4th Circ. Says Execs' Optimism Wasn't Fraud In Merger Suit
The Fourth Circuit on Monday affirmed a lower court's dismissal of a class action from investors of two merged pharmaceutical companies who said the companies and their executives were too optimistic...To view the full article, register now.
Already a subscriber? Click here to view full article